KR960704855A
(en)
|
1993-10-12 |
1996-10-09 |
돈 엠. 커. |
1N-Alkyl-N-arylpyrimidinamines and derivatives thereof
|
WO1995010506A1
(en)
*
|
1993-10-12 |
1995-04-20 |
The Du Pont Merck Pharmaceutical Company |
1n-alkyl-n-arylpyrimidinamines and derivatives thereof
|
IT1270122B
(en)
*
|
1994-10-04 |
1997-04-28 |
Ist Superiore Sanita |
6-BENZYL-4-OXYPYRIMIDIN REPLACED, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
|
US5733932A
(en)
*
|
1995-01-06 |
1998-03-31 |
The Picower Institute For Medical Research |
Compounds and methods of use to derivatize neighboring lysine residues in proteins under physiological conditions
|
RU2174978C2
(en)
*
|
1996-05-04 |
2001-10-20 |
Юхан Корпорейшн |
Method of synthesis of pyrimidine derivative, intermediate compounds and method of their synthesis
|
US6252076B1
(en)
|
1996-05-04 |
2001-06-26 |
Yuhan Corporation |
Process for preparation of pyrimidine derivatives
|
IN188411B
(en)
|
1997-03-27 |
2002-09-21 |
Yuhan Corp |
|
JP3507917B2
(en)
*
|
1998-03-27 |
2004-03-15 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
Pyrimidine derivatives that inhibit HIV
|
BRPI9909191B8
(en)
|
1998-03-27 |
2021-07-06 |
Janssen Pharmaceutica Nv |
hiv inhibitor pyrimidine derivatives, their use and pharmaceutical composition comprising them
|
EP0945442A1
(en)
*
|
1998-03-27 |
1999-09-29 |
Janssen Pharmaceutica N.V. |
Trisubstituted pyrimidine derivatives
|
IT1305313B1
(en)
*
|
1998-07-17 |
2001-05-04 |
Colla Paolo |
3,4 - DIHYDRO- 6- BENZYL-4-OXOPYRIMIDINE REPLACED AND RELATED PROCESS OF PRODUCTION AND USE IN THE THERAPY OF HIV-1 INFECTIONS.
|
EP1107958B1
(en)
|
1998-08-29 |
2006-08-16 |
AstraZeneca AB |
Pyrimidine compounds
|
EP1107957B1
(en)
|
1998-08-29 |
2006-10-18 |
AstraZeneca AB |
Pyrimidine compounds
|
KR100272471B1
(en)
|
1998-11-17 |
2000-11-15 |
김선진 |
Novel pyrimidine derivatives and processes for the preparation thereof
|
GB9828511D0
(en)
|
1998-12-24 |
1999-02-17 |
Zeneca Ltd |
Chemical compounds
|
EP1142881A4
(en)
*
|
1999-01-14 |
2003-05-07 |
Meiji Seika Kaisha |
Poly(adp-ribose) polymerase inhibitors consisting of pyrimidine derivatives
|
GB9905075D0
(en)
|
1999-03-06 |
1999-04-28 |
Zeneca Ltd |
Chemical compounds
|
GB9907658D0
(en)
|
1999-04-06 |
1999-05-26 |
Zeneca Ltd |
Chemical compounds
|
GB9919778D0
(en)
|
1999-08-21 |
1999-10-27 |
Zeneca Ltd |
Chemical compounds
|
DE19945982A1
(en)
*
|
1999-09-24 |
2001-03-29 |
Knoll Ag |
Velocity-determined particles
|
UA74797C2
(en)
|
1999-09-24 |
2006-02-15 |
Янссен Фармацевтика Н.В. |
Antiviral composition
|
GB0004888D0
(en)
|
2000-03-01 |
2000-04-19 |
Astrazeneca Uk Ltd |
Chemical compounds
|
GB0004887D0
(en)
|
2000-03-01 |
2000-04-19 |
Astrazeneca Uk Ltd |
Chemical compounds
|
GB0004890D0
(en)
|
2000-03-01 |
2000-04-19 |
Astrazeneca Uk Ltd |
Chemical compounds
|
GB0004886D0
(en)
|
2000-03-01 |
2000-04-19 |
Astrazeneca Uk Ltd |
Chemical compounds
|
GB0007371D0
(en)
|
2000-03-28 |
2000-05-17 |
Astrazeneca Uk Ltd |
Chemical compounds
|
JP4969010B2
(en)
|
2000-05-08 |
2012-07-04 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
Prodrug of HIV replication inhibitory pyrimidine
|
US7276510B2
(en)
|
2000-05-08 |
2007-10-02 |
Janssen Pharmaceutica, Inc. |
HIV replication inhibitors
|
US6545007B2
(en)
|
2000-11-17 |
2003-04-08 |
Idenix (Cayman) Limited |
Methods for inhibiting the transmission of HIV using topically applied substituted 6-benzyl-4-oxopyrimidines
|
GB0016877D0
(en)
|
2000-07-11 |
2000-08-30 |
Astrazeneca Ab |
Chemical compounds
|
GB0021726D0
(en)
|
2000-09-05 |
2000-10-18 |
Astrazeneca Ab |
Chemical compounds
|
UA80393C2
(en)
|
2000-12-07 |
2007-09-25 |
Алтана Фарма Аг |
Pharmaceutical preparation comprising an pde inhibitor dispersed on a matrix
|
GB0103926D0
(en)
|
2001-02-17 |
2001-04-04 |
Astrazeneca Ab |
Chemical compounds
|
GB0113041D0
(en)
|
2001-05-30 |
2001-07-18 |
Astrazeneca Ab |
Chemical compounds
|
US6825198B2
(en)
|
2001-06-21 |
2004-11-30 |
Pfizer Inc |
5-HT receptor ligands and uses thereof
|
JO3429B1
(en)
|
2001-08-13 |
2019-10-20 |
Janssen Pharmaceutica Nv |
Hiv inhibiting pyrimidines derivatives
|
EP2090571B1
(en)
|
2001-10-17 |
2012-05-16 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Pyrimidine derivates, medicaments comprising them, their use and process of their preparation
|
EP1453516A2
(en)
|
2001-10-17 |
2004-09-08 |
Boehringer Ingelheim Pharma GmbH & Co.KG |
Novel tri-substituted pyrimidines, method for production and use thereof as medicament
|
CN100436427C
(en)
*
|
2001-11-01 |
2008-11-26 |
詹森药业有限公司 |
Aminobenzamide derivatives as glycogen synthase kinase 3 beta inhibitors
|
AU2002363176B2
(en)
|
2001-11-01 |
2008-09-25 |
Janssen Pharmaceutica N.V. |
Heteroaryl amines as glycogen synthase kinase 3Beta inhibitors (GSK3 inhibitors)
|
TWI329105B
(en)
|
2002-02-01 |
2010-08-21 |
Rigel Pharmaceuticals Inc |
2,4-pyrimidinediamine compounds and their uses
|
MY140561A
(en)
|
2002-02-20 |
2009-12-31 |
Nycomed Gmbh |
Dosage form containing pde 4 inhibitor as active ingredient
|
GB0205688D0
(en)
|
2002-03-09 |
2002-04-24 |
Astrazeneca Ab |
Chemical compounds
|
EP1490354A1
(en)
|
2002-03-09 |
2004-12-29 |
Astrazeneca AB |
4-imidazolyl substituted pyrimidine derivatives with cdk inhibitory activity
|
GB0205693D0
(en)
|
2002-03-09 |
2002-04-24 |
Astrazeneca Ab |
Chemical compounds
|
GB0205690D0
(en)
|
2002-03-09 |
2002-04-24 |
Astrazeneca Ab |
Chemical compounds
|
MXPA05001096A
(en)
|
2002-07-29 |
2005-11-23 |
Rigel Pharmaceuticals Inc |
Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds.
|
US7157455B2
(en)
|
2003-02-10 |
2007-01-02 |
Hoffmann-La Roche Inc. |
4-Aminopyrimidine-5-one derivatives
|
GB0311276D0
(en)
|
2003-05-16 |
2003-06-18 |
Astrazeneca Ab |
Chemical compounds
|
GB0311274D0
(en)
|
2003-05-16 |
2003-06-18 |
Astrazeneca Ab |
Chemical compounds
|
HRP20130602T1
(en)
|
2003-07-30 |
2013-07-31 |
Rigel Pharmaceuticals, Inc. |
2,4-pyrimidinediamine compounds for use in the treatment or prevention of autoimmune diseases
|
TW200528101A
(en)
|
2004-02-03 |
2005-09-01 |
Astrazeneca Ab |
Chemical compounds
|
EP2543376A1
(en)
|
2004-04-08 |
2013-01-09 |
Targegen, Inc. |
Benzotriazine inhibitors of kinases
|
US7405220B2
(en)
|
2004-06-09 |
2008-07-29 |
Hoffmann-La Roche Inc. |
Pyrazolopyrimidines
|
KR20070057798A
(en)
|
2004-09-30 |
2007-06-07 |
티보텍 파마슈티칼즈 리미티드 |
Pyrimidine substituted with 5-carbocycle or heterocycle that inhibits HIV
|
ATE540035T1
(en)
|
2004-11-24 |
2012-01-15 |
Rigel Pharmaceuticals Inc |
SPIRO-2,4-PYRIMIDINEDIAMINE COMPOUNDS AND USES THEREOF
|
CN101115761B
(en)
|
2005-01-19 |
2012-07-18 |
里格尔药品股份有限公司 |
Prodrugs of 2,4-pyrimidinediamine compounds and their uses
|
AR056556A1
(en)
|
2005-09-30 |
2007-10-10 |
Astrazeneca Ab |
IMIDAZO (1,2-A) PIRIDINE WITH CELLULAR ANTIPROLIFERATION ACTIVITY
|
NZ567851A
(en)
|
2005-11-01 |
2011-09-30 |
Targegen Inc |
Bi-aryl meta-pyrimidine inhibitors of kinases
|
US7705009B2
(en)
|
2005-11-22 |
2010-04-27 |
Hoffman-La Roche Inc. |
4-aminopyrimidine-5-thione derivatives
|
WO2008061112A2
(en)
*
|
2006-11-14 |
2008-05-22 |
Myriad Genetics, Inc. |
Pharmaceutical compounds as inhibitors of cell proliferation and the use thereof
|
AU2008323628B2
(en)
|
2007-11-15 |
2013-10-17 |
Ym Biosciences Australia Pty Ltd |
N-containing heterocyclic compounds
|
WO2012060847A1
(en)
|
2010-11-07 |
2012-05-10 |
Targegen, Inc. |
Compositions and methods for treating myelofibrosis
|
WO2018187652A1
(en)
|
2017-04-06 |
2018-10-11 |
Janssen Pharmaceutica Nv |
2,4-diaminopyrimidine derivatives as histamine h4 modulators
|